ANDEMBRY INJVLST 167MG/ML PEN 1,2ML
- Active substance
- GARADACIMAB
- Therapeutical formulation
- INJECTIEVLOEISTOF
-
€ 18,177.64 € 18,177.64 excluding delivery costs. Delivery costs are the costs your pharmacist charges for delivering the medicine.
- Own risk
-
€ 18,177.64 € 18,177.64
- Strength
- 166,667MG/ML
- Supplier
- CSL BEHRING BV
- Available outside pharmacies
- No
- Remarks
-
- This medicine is available by prescription only.
- EU number
- EU/1/24/1885/003
Alternatives
- TAKHZYRO INJVLST 150MG/ML WWSP 2ML € 13,444.22 per piece Vergoed
- TAKHZYRO INJVLST 150MG/ML WWSP 2ML € 13,444.22 per piece Vergoed
- TAKHZYRO INJVLST 150MG/ML WWSP 2ML € 13,444.22 per piece Vergoed
- TAKHZYRO INJVLST 150MG/ML WWSP 2ML € 13,444.22 per piece Vergoed
- TAKHZYRO INJVLST 150MG/ML WWSP 2ML € 13,444.23 per piece Vergoed
- TAKHZYRO INJVLST 150MG/ML WWSP 2ML € 13,444.23 per piece Vergoed
- TAKHZYRO INJVLST 150MG/ML PEN 2ML € 13,945.24 per piece Vergoed
- TAKHZYRO INJVLST 150MG/ML PEN 2ML € 13,945.25 per piece Vergoed
- TAKHZYRO INJVLST 150MG/ML FLACON 2ML € 13,945.25 per piece Vergoed
- TAKHZYRO INJVLST 150MG/ML PEN 2ML € 13,945.25 per piece Vergoed
- TAKHZYRO INJVLST 150MG/ML WWSP 1ML € 13,945.25 per piece Deels vergoed